EMEA-002272-PIP01-17

Key facts

Active substance
Entinostat Polymorph B
Therapeutic area
Oncology
Decision number
P/0087/2018
PIP number
EMEA-002272-PIP01-17
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of breast malignant neoplasms
Route(s) of administration
Oral use
Contact for public enquiries
Syndax Pharmaceuticals, Inc.
Tel. +44(0) 7723045990
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating